Aboukarr A, Giudice M. 2018. Interaction between Monoamine Oxidase B Inhibitors and Selective Serotonin Reuptake Inhibitors. Can J Hosp Pharm. 71(3):196-207.

Collados V, Hallal H, Andrade RJ. 2010. Sertraline hepatotoxicity: report of a case and review of the literature. Dig Dis Sci. 55(6):1806-1807.

Ewing G, Tatarchuk Y, Appleby D, Schwartz N, Kim D. 2015. Placental transfer of antidepressant medications: implications for postnatal adaptation syndrome. Clin Pharmacokinet. 54(4):359–370. doi: 10.1007/s40262-014-0233-3.

Friedrich ME, Akimova E, Huf W, Konstantinidis A, Papageorgiou K, Winkler D, et al. 2016. Drug-Induced Liver Injury during Antidepressant Treatment: Results of AMSP, a Drug Surveillance Program. Int J Neuropsychopharmacol. 19(4):pyv126. doi: 10.1093/ijnp/pyv126.

Hannestad J, DellaGioia N, Bloch M. 2011. The effect of antidepressant medication treatment on serum levels of inflammatory cytokines: a meta-analysis. Neuropsychopharmacology. 36: 2452–2459.

Hashimoto, K. 2009. "Sigma-1 Receptors and Selective Serotonin Reuptake Inhibitors: Clinical Implications of their Relationship". Cent Nerv Syst Agents Med Chem. 9:197–204.

Heinonen E, Blennow M, Blomdahl-Wetterholm M, Hovstadius M, Nasiell J, Pohanka A, et al. 2021. Sertraline concentrations in pregnant women are steady and the drug transfer to their infants is low. Eur J Clin Pharmacol. 77(9):1323-1331. doi: 10.1007/s00228-021-03122-z. Epub 2021 Mar 22.

Hendrick V, Stowe ZN, Altshuler LL, Hwang S, Lee E, Haynes D. 2003. "Placental passage of antidepressant medications". Am. J. Psychiatry. 160(5):993-6.

Hostetter A, Ritchie JC, Stowe ZN. 2000. "Amniotic fluid and umbilical cord blood concentrations of antidepressants in three women". Biol. Psychiatry. 48 (10):1032-4.

Huddart R, Hicks JK, Ramsey LB, Strawn JR, Smith DM, Bobonis Babilonia M, et al. 2020. PharmGKB summary: sertraline pathway, pharmacokinetics. Pharmacogenet Genomics. 30(2):26–33. doi: 10.1097/FPC.0000000000000392.

Jajoo A, Donlon C, Shnayder S, Levin M, McVey M. 2020. Sertraline induces DNA damage and cellular toxicity in Drosophila that can be ameliorated by antioxidants. Sci Rep. 10(1):4512. doi: 10.1038/s41598-020-61362-y.

Letafat Farashbandi A, Shariati M, Mokhtari M. 2021. Comparing the Protective Effects of Curcumin and Ursodeoxycholic Acid after Ethanol-Induced Hepatotoxicity in Rat Liver. Ethiop J Health Sci. 31 (3):673.

Mikail HG, Dalla C, Kokras N, Kafetzopoulos V, Papadopoulou-Daifoti Z. 2012. Sertraline behavioral response associates closer and dose-dependently with cortical rather than hippocampal serotonergic activity in the rat forced swim stress. Physiol Behav. 107(2):201-6.

Molenaar NM, Bais B, Lambregtse-Van Den Berg MP, Mulder CL, Howell EA, Fox NS, Rommel A-S, et al. 2020. The international prevalence of antidepressant use before, during, and after pregnancy: a systematic review and meta-analysis of timing, type of prescriptions and geographical variability. J Affect Disord. 264:82–89. doi: 10.1016/j.jad.2019.12.014.

Obach RS, Cox LM, Tremaine LM. 2005. "Sertraline is metabolized by multiple cytochrome P450 enzymes, monoamine oxidases, and glucuronyl transferases in human: an in vitro study". Drug Metab. Dispos. 33(2):262–70.

Pereira-Figueiredo I, Sancho C, Carro J, Castellano O, López DE. 2014. The effects of sertraline administration from adolescence to adulthood on physiological and emotional development in prenatally stressed rats of both sexes. Front Behav Neurosci. 8:260.

Hilal-Dandan R, Brunton L, Goodman LS. 2013. Goodman and Gilman Manual of Pharmacology and Therapeutics. 2nd ed. McGraw Hill Professional: p. 247.

Shen ZQ, Gao SY, Li SX, Zhang TN, Liu CX, Lv HC, et al. 2017. Sertraline use in the first trimester and risk of congenital anomalies: a systemic review and meta-analysis of cohort studies. Br J Clin Pharmacol. 83(4):909-922. doi: 10.1111/bcp.13161.

Sitges M, Gómez CD, Aldana BI. 2014. Sertraline reduces IL-1β and TNF-α mRNA expression and overcomes their rise induced by seizures in the rat hippocampus. PLoS One. 9(11):e111665. doi: 10.1371/journal.pone.0111665.

Stowe ZN, Hostetter AL, Owens MJ, Ritchie JC, Sternberg K, Cohen LS, et al. 2003. "The pharmacokinetics of sertraline excretion into human breast milk: determinants of infant serum concentrations". J Clin Psychiatry J CLIN PSYCHIAT. 64(1):73–80.

Suen CF, Boyapati R, Simpson I, Dev A. 2013. Acute liver injury secondary to sertraline. BMJ Case Rep. 26(2013):bcr2013201022. doi: 10.1136/bcr-2013-201022.

Tabak F, Gunduz F, Tahan V, Tabak O, Ozaras R. 2009. Sertraline hepatotoxicity: report of a case and review of the literature. Dig dis sci. 54(7):1589-1591.

Wang J, Wu X, Lai W, Long E, Zhang X, Li W, et al. 2017. Prevalence of depression and depressive symptoms among outpatients: a systematic review and meta-analysis. BMJ Open. 7(8):e017173. doi: 10.1136/bmjopen-2017-017173.

Westin AA, Brekke M, Molden E, Skogvoll E, Spigset O. 2017. Selective serotonin reuptake inhibitors and venlafaxine in pregnancy: changes in drug disposition. PLoS One. 12(7):e0181082. doi: 10.1371/journal.pone.0181082.

Wise LD, Dostal LA, DeSesso JM. 2020. The teratogenic effects of sertraline in mice. Birth Defects Res. 112(13):1025-1027. doi: 10.1002/bdr2.1751.

Yabut JM, Crane JD, Green AE, Keating DJ, Khan WI, Steinberg GR. 2019. Emerging Roles for Serotonin in Regulating Metabolism: New Implications for an Ancient Molecule. Endocr Rev. 40(4):1092–1107. https://doi.org/10.1210/er.2018-00283.